Key takeaway: Tilaknagar Industries Limited reported its unaudited financial results for the quarter ended June 30, 2026, highlighting a robust performance with a 9% quarter-on-quarter volume growth, driven by the Imperial Blue brand, which saw an 18% increase. The company noted that approximately 90% of Imperial Blue operations had transitioned out of the Transition Services and Manufacturing Agreement (TSMA), with only one state remaining. Despite inflationary pressures impacting gross margins, management expressed confidence in improving the EBITDA margin from the previous quarter's 15.5%. The presentation also detailed a significant increase in net revenue to INR 1,046 crore, marking a 166% year-on-year growth. Management indicated that the integration of Imperial Blue would allow for a focus on long-term growth and expansion into luxury and super-premium segments. The company also reported a net profit of INR 76 crore, reflecting a 52% year-on-year increase.

Key takeaway: Tilaknagar Industries Limited held its earnings conference call on May 30, 2026, to discuss Q4 and FY26 results. Management highlighted significant achievements, including reaching nearly 20 million cases in volume for FY26 and Mansion House Brandy becoming India's largest P&A brandy. Overall volumes increased by 68% for FY26, with a 135% year-on-year growth in Q4. The company reported a net revenue of INR 949 crore for Q4, a 148% increase, and an EBITDA of INR 155 crore, marking a 97% growth. Management discussed a change in revenue recognition that would impact reported revenue but improve EBITDA margins. They outlined a focus on demand generation, operational efficiency, and capital management. The company also announced a dividend of INR 1 per share for FY25-'26. The call concluded with management expressing optimism about future growth opportunities and the integration of the Imperial Blue business.

Key takeaway: Tilaknagar Industries Limited reported a sales volume of approximately 20 million cases for FY26, including 4 months of Imperial Blue under its ownership. Mansion House Brandy achieved record sales of 10 million cases, marking a 68% year-over-year volume growth for the combined business. The earnings presentation highlighted a 135% year-over-year volume increase in Q4 FY26, with the Imperial Blue business growing by 9% in volume terms compared to Q4 FY25. Management outlined four strategic goals for the next three years, including achieving double-digit volume growth and optimizing operational efficiencies to reach an EBITDA margin of 16-18%. The company also announced a dividend of Re. 1 per equity share for FY26. Despite anticipated pressure on input costs due to geopolitical tensions, management expressed confidence in maintaining guidance for volume and margin growth.

Key takeaway: The earnings conference call for Tilaknagar Industries Limited on February 13, 2026, discussed the Q3 FY26 results, marking the first quarter of reporting post-acquisition of Imperial Blue. Management reported a combined secondary sale of 2.1 million cases in December 2025, leading to a 32% market share in the prestige and above IMFL segment. Overall volumes increased by 76.1% year-on-year to 5.3 million cases, with net revenue growing by 90.5% to Rs. 664 crore. EBITDA for Q3 FY26 reached Rs. 110 crore, reflecting an 82.3% growth. Management highlighted the launch of Seven Islands Pure Malt whisky and ongoing integration efforts for Imperial Blue, including cost-saving initiatives. They guided toward a high-single digit volume growth for Imperial Blue in Q4 FY26 and a projected low-double digit growth for FY27. The call concluded with management expressing confidence in sustainable growth and margin improvement.

Key takeaway: Tilaknagar Industries Limited's investor presentation for the quarter and nine months ended December 31, 2025, reported significant growth following the acquisition of Imperial Blue. Management highlighted that Imperial Blue sold 1.79 million cases in its first month under Tilaknagar's ownership, contributing to a 76.1% year-on-year increase in total volumes to 53.1 lakh cases. The presentation detailed a net revenue of INR 664 crores for Q3FY26, reflecting a 95.0% increase year-on-year, and a 43.1% increase to INR 1,471 crores for the nine-month period. EBITDA for Q3FY26 was reported at INR 90 crores, with a margin of 14.0%. Management set clear goals for restoring Imperial Blue's market leadership, expanding margins, and reducing net debt to below 1.0x by FY29. The presentation emphasized a strategic focus on premiumization and integration of the acquired business.